Very late-onset membranous nephropathy secondary to alemtuzumab in a patient with multiple sclerosis
Nefropatía membranosa muy tardía secundaria a alemtuzumab en paciente con esclerosis múltiple
Área salud
Systematic review of gender bias in clinical trials of monoclonal antibodies for the treatment of multiple sclerosis
Introduction This article analyses the presence of gender bias in clinical trials of monoclonal antibodies used to treat multiple sclerosis. Material and methods We performed a systematic review of controlled clinical trials of 4 monoclonal […]
Área salud
Autoimmune eye diseases in multiple sclerosis
Introduction The eye is a complex organ that can present complications related to autoimmune diseases, including multiple sclerosis (MS). Ocular manifestations may act as early indicators of autoimmune diseases, and their early diagnosis and treatment […]
Área salud
Comparative study of infusion-related reactions to anti-CD20 drugs in neuroimmunological diseases of the central nervous system: a retrospective analysis of ocrelizumab and rituximab treatments
Introduction The anti-CD20 monoclonal antibodies, rituximab (RTX) and ocrelizumab (OCRE), are used routinely for the treatment of neuroimmunological diseases. However, infusion-related reactions (IRRs) are common, and their underlying mechanisms are not well defined. Objectives Our […]